FirsthandHealth
medRxiv PreprintsInternational20 November 2026

Single-cell profiling reveals venom-specific T-cells associated with tolerance during immunotherapy

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Background: Venom immunotherapy (VIT) is well established, but the dynamics of the rare venom-specific T cells during treatment need to be investigated. Defining these responses may identify biomarkers and pathways associated with treatment-induced tolerance. Methods: We sampled nine wasp-allergic individuals before and 7 days and 6 months after initiation of VIT, and 5 non-allergic donors at one time point. Single-cell RNA sequencing of isolated venom-specific T cells was used to characterise changes to immunophenotypes and immune receptor repertoires during VIT. Results: We unveiled a broad
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.